Stay updated on UNCOVER-2: Guselkumab Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a clarified note that PubMed publications are automatically filled in from PubMed and may not be about the study, replacing the previous PubMed description. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check32 days agoChange DetectedRemoved the notice about a lapse in government funding and the NIH Clinical Center's operating status. The page no longer displays that funding-status banner.SummaryDifference0.2%

- Check46 days agoChange DetectedNo significant changes were observed between the two screenshots. Core details such as eligibility criteria, primary outcomes, and study design appear unchanged.SummaryDifference0.2%

- Check75 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference0.9%

- Check82 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.1%

- Check97 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.1%

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.